Skip to main content

Table 3 Pregnancy outcomes from fresh/frozen-thawed embryo transfers in two groups

From: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial

Characteristics

MPA + HMG Group-FET

Ultra-long Group-ET

Ultra-long Group-FET

P

Patients (n)

129

100

33

 

Patients of ET (n)

0

100

  

Patients of FET

113

 

48

 

FET cycles (n)

157

 

68

 

Embryo before thawed

286

/

115

 

Viable embryo after thawed

286

/

115

 

Transferred embryos per cycle (n)

1.9 ± 0.4

1.8 ± 0.4

1.8 ± 0.5

0.236

Endometrial thickness (mm)

11.3 ± 1.6

11.7 ± 2.9

11.5 ± 2.3

0.351

Clinical pregnancy rate per (%)

50.31 (79/157)

55(55/100)

48.53 (33/68)

0.665

Implantation rate (%)

34.27 (98/286)

33.85 (65/192)

39.67 (48/121)

0.517

Ectopic pregnancy rate (%)

1.27 (1/79)

1.81 (1/55)

0 (0/33)

0.747

Multiple pregnancy rate (%)

30.38 (24/79)

21.81 (12/55)

36.36(12/33)

0.312

Miscarriage rate (%)

11.39 (9/79)

9.09 (5/55)

21.21 (7/33)

0.229

Ongoing pregnant rate per transfer (%)

43.95 (69/157)

49 (49/100)

38.23 (26/68)

0.384

Cumulative pregnancy rate per woman (%)

61.01 (69/113)

50 (50/100)

56.25 (28/48)

0.479

Gestation, w

37.87 ± 2.07

38.33 ± 2.10

37.00 ± 2.22

0.879

Birth length, cm

49.35 ± 1.35

49.56 ± 1.23

49.16 ± 1.22

0.568

Birth weight, g

3030.6 ± 642.8*

3087.5 ± 564.01#

2633.9 ± 634.9*#

0.007

Child’s sex-male, no. (%)

55.43 (51/92)

52.72 (39/55)

51.72 (15/29)

0.484

Live birth, no. (%)

43.95 (69/157)

49 (49/100)

39.71 (27/68)

0.48

Complications during pregnancy and postpartum (%)

8.85 (10/113)

5 (5/100)

8.51 (4/47)

0.532

Birth malformation rate (%)

0.98 (1/102)

0 (0/100)

0 (0/43)

0.602

  1. *P < 0.0167 MPA + HMG group vs Ultra-long Group-ET group; #P < 0.0167 Ultra-long Group-ET vs Ultra-long Group-FET group
  2. FET, frozen-thawed embryo transfer